PURE Bioscience, Inc. Share Price Other OTC
Equities
PURE
US74621T2096
Household Products
Sales 2022 | 1.85M 154M | Sales 2023 | 1.88M 156M | Capitalization | 9.51M 792M |
---|---|---|---|---|---|
Net income 2022 | -3M -250M | Net income 2023 | -3M -250M | EV / Sales 2022 | 10.2 x |
Net cash position 2022 | 3.39M 282M | Net cash position 2023 | 74K 6.16M | EV / Sales 2023 | 5.03 x |
P/E ratio 2022 |
-5.08
x | P/E ratio 2023 |
-2.39
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 59.55% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Bartlett
CEO | Chief Executive Officer | 79 | 08/23/08 |
Mark Elliott
DFI | Director of Finance/CFO | 48 | 01/04/01 |
Dolana Blount
CTO | Chief Tech/Sci/R&D Officer | - | 01/98/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Bartlett
CEO | Chief Executive Officer | 79 | 08/23/08 |
Tom Myers
CTO | Chief Tech/Sci/R&D Officer | 71 | 09/11/09 |
Tom Lee
BRD | Director/Board Member | 75 | 24/14/24 |
1st Jan change | Capi. | |
---|---|---|
-15.26% | 41.09B | |
-4.89% | 16.84B | |
-23.23% | 6.48B | |
+7.71% | 6.08B | |
-0.17% | 3.23B | |
+1.03% | 2.35B | |
-6.51% | 1.95B | |
+25.39% | 948M | |
-1.20% | 645M |